Source: Health Products Regulatory Authority (ZA) Revision Year: 2024 Publisher: UNIMED HEALTHCARE (PTY) LTD, Corner Birch Road & Bluegum Avenue, Anchorville, Lenasia, 1827, South Africa, Tel: +27 11 056 6999
CLAVUMED 375 (film-coated tablet).
CLAVUMED 625 mg (film-coated tablet).
Pharmaceutical Form |
---|
Clavumed 375: White to off-white oval shaped biconvex, film coated tablets imprinted with ‘R375’ in black ink on one side. Clavumed 625: White to off-white oval shaped biconvex, film coated tablets imprinted with ‘R625’ in black ink on one side. |
CLAVUMED 375:
Each tablet contains:
Amoxicillin trihydrate equivalent to amoxicillin 250 mg and
Potassium clavulanate equivalent to clavulanic acid 125 mg
Butylhydroxytoluene (as antioxidant) 0,46% m/m
CLAVUMED 625 mg:
Each tablet contains:
Amoxicillin trihydrate equivalent to amoxicillin 500 mg and
Potassium clavulanate equivalent to clavulanic acid 125 mg
Butylhydroxytoluene (as antioxidant) 0,46% m/m
Sugar free.
For full list of excipients, see section 6.1.
Active Ingredient |
---|
Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death. |
Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin. |
List of Excipients |
---|
CLAVUMED tablets also contain the following excipients: Tablet core: Colloidal anhydrous silica Tablet film-coating consisting of: Hypromellose |
Clavumed 375:
Aluminium strip pack containing 15 and 100 tablets in a carton.
Clavumed 625:
Aluminium strip pack containing 15 tablets in a carton.
UNIMED HEALTHCARE (PTY) LTD, Corner Birch Road & Bluegum Avenue, Anchorville, Lenasia, 1827, South Africa, Tel: +27 11 056 6999
Clavumed 375: 33/20.1.2/0461
Clavumed 625: 33/20.1.2/0462
Date of registration: 6 April 2022 – CLAVUMED 375
Date of registration: 6 April 2022 – CLAVUMED 625 mg
Drug | Countries | |
---|---|---|
CLAVUMED | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.